M.V. LARIONOV^1,2, R.K. KHAFISIANOVA², O.V. CHUENKOV¹, I.I. SHAMSUTDINOVA^1,2, N.B. SADEKOV¹

¹Republican Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

²Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012 

Larionov M.V. — Cand. Med. Sc., Assistant of the Surgery Department №1, Doctor of the Department of Vascular Surgery №2, tel.: (843) 231-21-62, +7-917-257-02-05, e-mail: [email protected]

Khafisianova R.K. — D. Med. Sc., Professor of the Department of Pharmacology, tel. +7-917-296-04-11, e-mail: [email protected]

Chuenkov O.V. — Head of the Department of Vascular Surgery №2, tel. (843) 231-21-62, e-mail: [email protected]

Shamsutdinova I.I. — Doctor of the Department of Functional Diagnostics, tel. +7-927-670-04-55, e-mail: [email protected]

Sadekov N.B. — Doctor of the Department of Vascular Surgery №2, tel.: (843) 231-21-62, +7-917-289-34-49, e-mail: [email protected]

This article is devoted to an actual problem of modern medicine ― the treatment tactics of patients with superficial thrombophlebitis of the lower extremities. The results of patients’ treatment with combined lesions of the superficial and deep venous system of the lower limbs are presented that demonstrate the Rivaroxaban efficacy and safety.

Key words: acute venous thrombosis, superficial thrombophlebitis, oral anticoagulants, Rivaroxaban.

 

 

REFERENCES

1. Decousus H., Prandoni P., Mismetti P. et al, CALISTO Study Group. Fondaparinux in the treatment of lower-limb superficial vein thrombosis. N. Engl. J. Med, 2010, 363, pp. 1222-32.
2. Galanaud J.P., Genty C., Sevestre M.A. et al the OPTIMEV SFMV investigators. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of super fi cial venous thrombosis. The OPTI-MEV study. Thromb Haemost, 2011, 105, pp. 31-9.
3. Decousus H., Bertoletti L., Frappe P. Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat? J. Thromb. Haemost, 2015, 13 (suppl. 1), s. 230-s7.
4. Russian clinical recommendations for diagnosis, treatment and prevention of venous thromboembolic events (VTEC). Flebologiya, 2015, vol. 9, no. 4, iss. 2 (in Russ.).
5. EINSTIEN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N. Engl. J. Med, 2010 Dec, 23, 363 (26), pp. 2499-2510.